University of Toronto
Christopher J.D. Wallis is a Urologic Oncologist at the University of Toronto and Mount Sinai Hospital. He obtained his Doctor of Medicine from the University of British Columbia and his Doctor of Philosophy in Clinical Epidemiology & Health Care Research from the Institute of Health Policy, Management & Evaluation at the University of Toronto and completed his clinical residency in Urology at the University of Toronto affiliated hospitals and his Society of Urologic Oncology accredited fellowship training at Vanderbilt University Medical Center. His research focuses on leveraging a variety of epidemiologic techniques to understand and improve care for patients with urologic conditions, particularly prostate cancer.
His work has been funded by peer-reviewed grants from the Canadian Institute for Health Research (CIHR), the Canadian Urological Association Scholarship Foundation (CUASF), the Physicians’ Services Incorporation (PSI) Foundation, the Ontario Ministry of Health and Long-term Care, and the Ontario Student Opportunity Trust Funds (OSOTF).
He has been recognized with awards from the American Urological Association (AUA), the Society of Urologic Oncology, the Canadian Society for Clinical Investigation (CSCI), the AUA Northeast Section, the University of Toronto Institute of Health Policy, Management & Evaluation (IHPME), the University of Toronto Postgraduate Medical Education, the University of Toronto Division of Urology, and the University of British Columbia Department of Surgery.
He has over 150 peer-reviewed publications, as well as invited editorials, commentaries, and letters to the editor, including high-impact journals such as The New England Journal of Medicine (NEJM), the Journal of the American Medical Association (JAMA), The BMJ, JAMA Oncology, JAMA Internal Medicine, The Lancet Diabetes & Endocrinology, The Journal of the National Cancer Institute (JNCI) and European Urology. Further, He acts as a consulting editor at European Urology and at PlosOne and is an invited editorialist at major journals including The BMJ, European Urology, Journal of Urology, and Nature Reviews Urology. Finally, he is an invited peer reviewer for The New England Journal of Medicine, The BMJ, the Journal of the National Cancer Institute, Cancer, European Urology, Journal of Urology, The Lancet Diabetes & Endocrinology, Medical Decision Making Policy & Practice, and Urologic Oncology, among many others and has been invited as a reviewer in the granting process by Cancer Research UK in their Tobacco Advisory Group and in the guideline review process for the American Urological Association Microhematuria Guidelines.
Disclosure information not submitted.
Monday, May 1, 2023
7:00 AM – 9:00 AM CST